Are there patients with T1 to T2, lymph node-negative breast cancer who are “high-risk” for locoregional disease recurrence?
Author:
Affiliation:
1. Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center; New York New York
2. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center; New York New York
Funder
National Institutes of Health
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.30658/fullpdf
Reference28 articles.
1. Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy;Abi-Raad;Int J Radiat Oncol Biol Phys,2011
2. Whose disease will recur after mastectomy for early stage, node-negative breast cancer? A systematic review;Kent;Clin Breast Cancer,2015
3. Present-day locoregional control in patients with T1 or T2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy;Sharma;Ann Surg Oncol,2010
4. Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy;Truong;Int J Radiat Oncol Biol Phys,2005
5. Can a subgroup of node-negative breast carcinoma patients with T1-2 tumor who may benefit from postmastectomy radiotherapy be identified?;Yildirim;Int J Radiat Oncol Biol Phys,2007
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The optimal regional irradiation volume for breast cancer patients: A comprehensive systematic review and network meta-analysis of published studies;Frontiers in Oncology;2023-01-31
2. IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer;BMC Cancer;2022-12-27
3. Survival outcomes after breast-conserving surgery plus radiotherapy compared with mastectomy in breast ductal carcinoma in situ with microinvasion;Scientific Reports;2022-11-22
4. Clinical outcomes of adjuvant radiotherapy for nodal negative T1 and T2 breast cancer;INT J RADIAT RES;2022
5. Post-Mastectomy Radiation Therapy: Applications and Advancements;Current Breast Cancer Reports;2022-04-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3